HOME >> MEDICINE >> NEWS
Researchers Identify Candidate Immunosuppressant With Fewer Side Effects

BOSTON-April 22, 1998--Researchers at Harvard Medical School and the Center for Blood Research have identified a peptide that may serve as a template for a drug that can suppress the immune response with fewer side effects than immunosuppressants currently available. In addition to benefiting people who receive organ transplants, a drug based on this agent potentially could be used to treat chronic conditions caused by excessive or inappropriate immune responses, such as asthma, inflammation, allergies, and rheumatoid arthritis. Their findings are published in the April 24 Molecular Cell.

The two main immunosuppressant drugs used today, cyclosporin A and FK506, prevent the rejection of foreign organs or bone marrow by disrupting the signaling pathway that activates T cells. But both drugs can cause kidney and nervous system damage, making them unsuitable for wider clinical application. The newly identified peptide prevents a single, specific step in the immune system's signaling pathway, so researchers anticipate that it will not cause serious side effects.

Anjana Rao, professor of pathology, Patrick Hogan, investigator, and their colleagues at Harvard Medical School and the Center for Blood Research made a peptide that binds to calcineurin, a key molecule in the pathway that transmits signals from the T cell receptor to the nucleus. The key difference between how the peptide and the drugs cyclosporin A and FK506 work is the region on calcineurin where each of these agents bind. Cyclosporin A and FK506 block the active site of calcineurin and prevent it from acting on any other molecules within the cell. The peptide, on the other hand, only blocks specific binding between calcineurin and NFAT (nuclear factor of activated T cells). Other calcineurin functions are unimpeded.

With the peptide in place, calcineurin is unable to bind to the transcription factor NFAT and the signaling pa
'"/>

Contact: Peta Gillyatt
pgillyat@warren.med.harvard.edu
617-432-0443
Harvard Medical School
24-Apr-1998


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... (PRWEB) , ... January 24, 2020 , ... The new ... days was quickly spread also to impact Thailand, Japan, and South Korea. The virus ... come in contact with live animals that were infected. , EPA has confirmed ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... in medical and scientific training, biomedical research, and patient care—today announced the recipients ... Office of Gender Equity in Science and Medicine. The awards aim to mitigate ...
(Date:1/23/2020)... , ... January 23, 2020 , ... Worldwide Business ... Organics Brand Director, Michelle Berger and Vice President of Dairy and Frozen, Jimmy ... Organics is a company that creates organic food and snack options at an affordable ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... memory impairment, has announced the Best Memory Care Facilities in Santa Rosa, California. ... facility features and amenities. , According to the Alzheimer’s Association , ...
(Date:1/23/2020)... , ... January 23, 2020 , ... Park Avenue based ... website jschildhorn.com. Dr. Schildhorn is excited to bring this new digital portal for patient ... Duke and attended medical school at Temple University. With over 12 years of hands-on ...
Breaking Medicine News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... With camaraderie and community ... men overcome addiction. , As a luxury drug and alcohol rehab center, it offers ... case manager to adventure therapy sessions and psychoeducational groups, Calusa is treating the entire ...
(Date:1/28/2020)... ... ... Rachel V. Rose, JD, MBA, a principal with Rachel V. Rose Attorney at ... 3rd Annual Healthcare Compliance Symposium co-hosted by Delaware Law School and First Healthcare ... of healthcare, securities and international law and business throughout her career. Her practice ...
(Date:1/28/2020)... , ... January 28, 2020 , ... Advanced foot ... and ankle wound care for over 20+ years in Livingston County. This medical ... foot and ankle ulcer or wound needs. , Many people are not aware that ...
Breaking Medicine Technology:
Cached News: